CTRI/2025/03/082156尚未招募3 期
Clinical evaluation of panchashireesh Agad churna pratisaran in tobacco chewing induced Sarvasar Mukhapaka (Oral Submucosal Fibrosis Grade 2)
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- Self
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- 1.The reduction in the gradation of symptoms or complete alleviation in
研究概览
简要总结
The study will conducted after obtaining permission from institutional ethical committee and will be registered ctri India as per inclusion criteria.patient will be selected and screening done at OPD and IPD of Agadtantra
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)(—)
- 性别
- All
入选标准
- •Tobacco chewing since 2-3 years Patient having clinical symptoms of OSMF 2.
排除标准
- •Patient with recurrent stomatitis due to nuetritional deficiency Patient diagnosed with oral squamous cell carcinoma.
结局指标
主要结局
1.The reduction in the gradation of symptoms or complete alleviation in
时间窗: 28 days
symptoms of OSMF will reveal the efficacy of Panchashireesh Agad churna in OSMF Grade II
时间窗: 28 days
caused by Tobacco chewing.
时间窗: 28 days
次要结局
- Worsening in the OSMF grade II symptoms will be measured as(secondary end point.)
研究者
Dr.Uday Dipak Shelar
Bharati Vidyapeeth (Deemed To Be University)college Of Ayurved,Pune
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
ayurvedic treatment of amavata (rheumatoid arthritis)CTRI/2025/02/080464Dr Anju S Raj132
尚未招募
2/3 期
Study of Lajjalu siddh tail and Lidocain 2 percent jelly local application in the treatment of parikartika (Fissure in Ano)CTRI/2024/12/077782Dr Arpit Gupta60
尚未招募
不适用
Management of Dushta Vrana with Ashwagandhadi LepaCTRI/2024/11/076795Government pg ayurved college and hospital chaukaghat varanasi uttar pradesh60
尚未招募
2/3 期
To evaluate the analgesic effect of patha nirgundi ghrita suppository in post operative pain in ano rectal surgeriesCTRI/2025/01/078922Dr Omkar Tukaram Khatkar60
尚未招募
2/3 期
A clinical study conducted to test how well Pathyadi Churna works in treating Kaphaj AtisaraCTRI/2025/06/089668Dr Shweta Vishwanath Suryawanshi60
